NanOlogy

About NanOlogy

NanOlogy, LLC is a clinical stage development company formed between DFB Pharmaceuticals, CritiTech, and US Biotest to advance our patented nanoparticle production technology platform for the treatment of cancer and other serious illnesses.
LEADERSHIP:
CEO: H. Paul Dorman
CLINICAL TRIAL:
Please click here for clinical trial information.
PRODUCTS:
All Products